Monthly Archive: September 2014

Sep 30

According to Bruce Ovbiagele, MD, of the Medical University of South Carolina in Charleston, and colleagues, patients with chronic kidney disease (CKD)

According to Bruce Ovbiagele, MD, of the Medical University of South Carolina in Charleston, and colleagues, patients with chronic kidney disease (CKD) treated with intravenous thrombolytic therapy during ischemic stroke had a higher risk for intracranial hemorrhage and serious systemic hemorrhage, but the risk did not appear to be related to their renal disease. The …

Continue reading »

Sep 30

The results are published in the October issue of the Journal of Thoracic Oncology.

A novel study reported only modest acute changes in cardiac biomarkers and electrocardiograms and no clinically significant cardiac events in patients with high–dose radiation exposure to the heart following thoracic radiation therapy (RT) and short–term follow–up. The results are published in the October issue of the Journal of Thoracic Oncology.

Sep 29

The American Heart Association and American College of Cardiology released an update of their guidelines for unstable angina and non-ST segment elevation myocardial infarction (NSTEMI)

The American Heart Association and American College of Cardiology released an update of their guidelines for unstable angina and non-ST segment elevation myocardial infarction (NSTEMI). The guidelines have replaced initial conservative management with “ischemia-guided strategy” in order to more clearly convey the physiologic rationale of this approach. The guideline is being published online in both …

Continue reading »

Sep 29

Serum copeptin, a surrogate biomarker for vasopressin, is higher in pregnant women who go on to develop preeclampsia, suggests a new study

Serum copeptin, a surrogate biomarker for vasopressin, is higher in pregnant women who go on to develop preeclampsia, suggests a new study. However, levels of copeptin were not elevated in women with other pregnancy complications, including gestational diabetes mellitus (GDM), gestational hypertension, and preterm birth. The study was published online in Hypertension.

Sep 28

The US Food and Drug Administration (FDA)

The US Food and Drug Administration (FDA) announced that a safety study of the asthma drug omalizumab suggests that it poses a slightly elevated but serious risk for heart attacks and ministrokes known as transient ischemic attacks.

Sep 28

A healthy diet, moderate alcohol consumption, a smaller waist circumference, and not smoking may each be independently associated with a lower risk of MI

A healthy diet, moderate alcohol consumption, a smaller waist circumference, and not smoking may each be independently associated with a lower risk of MI, suggested a large cohort study of healthy Swedish men. When these four lifestyle behaviors were combined with physical activity, individuals who adhered to all five healthy practices had an 86% lower …

Continue reading »

Sep 27

Saxagliptin, a selective dipeptidyl peptidase-4 (DPP-4) inhibitor

Saxagliptin, a selective dipeptidyl peptidase-4 (DPP-4) inhibitor, appears safe for use in diabetes patients with heart failure, unless they have very advanced heart failure and concomitant renal insufficiency, suggests a new study published in the journal Circulation.

Sep 27

Patients with diabetes have death rates that are similar to those with coronary artery disease (CAD)

Patients with diabetes have death rates that are similar to those with coronary artery disease (CAD) even when they fail to show abnormal myocardial perfusion single photon emission computed tomography (MPS), researchers said at the 19th Annual Meeting of the American Society of Nuclear Cardiology (ASNC).

Sep 26

The American Association for Thoracic Surgery (AATS)

The American Association for Thoracic Surgery (AATS) has issued new guidelines to help prevent the development of atrial fibrillation (AF) during or after surgery and for the clinical management of patients in whom AF or atrial flutter develops. The recommendations are published September 23 in the Journal of Thoracic and Cardiovascular Surgery.

Sep 26

Most treatment strategies used to treat acute venous thromboembolism (VTE)

Most treatment strategies used to treat acute venous thromboembolism (VTE) appear to be as safe and effective as the currently recommended combination of low-molecular-weight heparin (LMWH) plus a vitamin K antagonist; however, they are not interchangeable, suggests a large network analysis published recently in JAMA.

Older posts «